In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018–2020

References

• Shorr AF. Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature. Pharmacoeconomics. 2007;25(9):751–768. doi:10.2165/00019053-200725090-0000417803334
   PubMed Web of Science ®Google Scholar
• Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961;14(4):385–393. doi:10.1136/jcp.14.4.38513686776
   PubMed Web of Science ®Google Scholar
• Thampi N, Showler A, Burry L, et al. Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: impact of length of stay and intensity of care. Am J Infect Control. 2015;43(7):739–744. doi:10.1016/j.ajic.2015.01.03125769617
   PubMed Web of Science ®Google Scholar
• Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust. 2001;175(5):264–267. doi:10.5694/j.1326-5377.2001.tb143562.x11587259
   PubMed Web of Science ®Google Scholar
• Blaskovich MAT, Hansford KA, Butler MS, Jia Z, Mark AE, Cooper MA. Developments in glycopeptide antibiotics. ACS Infect Dis. 2018;4(5):715–735. doi:10.1021/acsinfecdis.7b0025829363950
   PubMed Web of Science ®Google Scholar
• Dong SD, Oberthur M, Losey HC, et al. The structural basis for induction of VanB resistance. J Am Chem Soc. 2002;124(31):9064–9065. doi:10.1021/ja026342h12149006
   PubMed Web of Science ®Google Scholar
• Vellappally S, Divakar D, Al Kheraif A, et al. Occurrence of vancomycin-resistant Staphylococcus aureus in the oral cavity of patients with dental caries. Acta Microbiol Immunol Hung. 2017;64(3):343–351. doi:10.1556/030.64.2017.03328889756
   PubMed Web of Science ®Google Scholar
• Centers for Disease C, Prevention. Update: staphylococcus aureus with reduced susceptibility to vancomycin–United States, 1997. MMWR Morb Mortal Wkly Rep. 1997;46(35):813–815.9310213
   PubMedGoogle Scholar
• Centers for Disease C, Prevention. Staphylococcus aureus resistant to vancomycin–United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51(26):565–567.12139181
   PubMedGoogle Scholar
• Wu Q, Sabokroo N, Wang Y, Hashemian M, Karamollahi S, Kouhsari E. Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates. Antimicrob Resist Infect Control. 2021;10(1):101. doi:10.1186/s13756-021-00967-y34193295
   PubMed Web of Science ®Google Scholar
• Shen P, Zhou K, Wang Y, et al. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China. J Antimicrob Chemother. 2019;74(9):2537–2543. doi:10.1093/jac/dkz23231203362
   PubMed Web of Science ®Google Scholar
• Zhu X, Liu C, Gao S, Lu Y, Chen Z, Sun Z. Vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolated from a patient who never received vancomycin treatment. Int J Infect Dis. 2015;33:185–190. doi:10.1016/j.ijid.2014.12.03825543098
   PubMed Web of Science ®Google Scholar
• Sharma M, Riederer K, Chase P, Khatib R. High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2008;27(6):433–437. doi:10.1007/s10096-007-0455-518214559
   PubMed Web of Science ®Google Scholar
• Jian J, Chen L, Xie Z, Zhang M. Dissemination of cfr-mediated linezolid resistance among Staphylococcus species isolated from a teaching hospital in Beijing, China. J Int Med Res. 2018;46(9):3884–3889. doi:10.1177/030006051878163629962305
   PubMed Web of Science ®Google Scholar
• Li S, Zhou Y, Li L, et al. cfrCharacterization of the multi-drug resistance gene in Methicillin-Resistant (MRSA) strains isolated from animals and humans in China. Front Microbiol. 2018;9:2925. doi:10.3389/fmicb.2018.0292530538695
   PubMed Web of Science ®Google Scholar
• Hsieh Y, Lin Y, Huang Y. Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality. Medicine. 2016;95(41):e5060. doi:10.1097/MD.000000000000506027741120
   PubMed Web of Science ®Google Scholar
• Zhuo C, Xu Y, Xiao S, Zhang G, Zhong N. Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006–2011 in China. Int J Antimicrob Agents. 2013;41(6):578–581. doi:10.1016/j.ijantimicag.2013.02.01423562222
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang M, Guo J, et al. CryptococcusIn vitro activities of the tetrazole VT-1161 compared with itraconazole and fluconazole against and non- species. Mycologia. 2021;29(9):1–8. doi:10.1080/00275514.2021.1913949
   Web of Science ®Google Scholar
• Diekema D, Pfaller M, Shortridge D, Zervos M, Jones R. Staphylococcus aureusTwenty-year trends in antimicrobial susceptibilities among from the SENTRY Antimicrobial Surveillance Program. Open Forum Infect Dis. 2019;6:S47–S53. doi:10.1093/ofid/ofy27030895214
   PubMed Web of Science ®Google Scholar
• Jian Y, Lv H, Liu J, et al. Staphylococcus aureusDynamic changes of susceptibility to vancomycin, teicoplanin, and linezolid in a central teaching hospital in Shanghai, China, 2008–2018. Front Microbiol. 2020;11:908. doi:10.3389/fmicb.2020.0090832528428
   PubMed Web of Science ®Google Scholar
• Jiang B, Yin S, You B, et al. Staphylococcus aureusA 5-year survey reveals increased susceptibility to glycopeptides for methicillin-resistant isolates from bacteremia patients in a Chinese burn center. Front Microbiol. 2017;8:2531. doi:10.3389/fmicb.2017.0253129312223
   PubMed Web of Science ®Google Scholar
• Phillips C, Wells N, Martinello M, Smith S, Woodman R, Gordon D. Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range. Infect Drug Resist. 2016;9:87–92. doi:10.2147/IDR.S10796127330319
   PubMed Web of Science ®Google Scholar
• Chang W, Ma X, Gao P, Lv X, Lu H, Chen F. Vancomycin MIC creep in methicillin-resistant Staphylococcus aureus (MRSA) isolates from 2006 to 2010 in a hospital in China. Indian J Med Microbiol. 2015;33(2):262–266. doi:10.4103/0255-0857.14883725865979
   PubMed Web of Science ®Google Scholar
• Lu C, Guo Y, Wang S, et al. Staphylococcus aureusDecreased vancomycin MICs among methicillin-resistant clinical isolates at a Chinese tertiary hospital over a 12-year period. Front Microbiol. 2016;7:1714. doi:10.3389/fmicb.2016.0171427833602
   PubMed Web of Science ®Google Scholar
• Choi E, Huh J, Lim C, et al. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive Care Med. 2011;37(4):639–647. doi:10.1007/s00134-011-2130-721253703
   PubMed Web of Science ®Google Scholar
• Miller C, Batra R, Cooper B, et al. An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection. Clin Infect Dis. 2012;54(5):591–600. doi:10.1093/cid/cir85822186774
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Moise-Broder P, Schentag J, Forrest A, Moellering R, Eliopoulos G. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004;42(6):2398–2402. doi:10.1128/JCM.42.6.2398-2402.200415184410
   PubMed Web of Science ®Google Scholar
• Fu X, Lin Z, Chen S, Hong L, Yu X, Wu S. Staphylococcus epidermidisTreatment of intracranial infection caused by methicillin-resistant with linezolid following poor outcome of vancomycin therapy: a case report and literature review. Infect Drug Resist. 2021;14:2533–2542. doi:10.2147/IDR.S31901334234481
   PubMed Web of Science ®Google Scholar
• Maraolo A, Giaccone A, Gentile I, Saracino A, Bavaro D. Daptomycin versus vancomycin for the treatment of methicillin-resistant bloodstream infection with or without Endocarditis: a systematic review and meta-analysis. Antibiotics. 2021;10(8):1014.34439067
   PubMed Web of Science ®Google Scholar
• Cojutti P, Scarparo C, Sartor A, Coato P, Rigoli R, Pea F. A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy. Diagn Microbiol Infect Dis. 2015;81(1):53–56. doi:10.1016/j.diagmicrobio.2014.09.01625301716
   PubMed Web of Science ®Google Scholar
• Yang X, Liu Y, Wang L, et al. Staphylococcus aureusClonal and drug resistance dynamics of methicillin-resistant in pediatric populations in China. Pediatr Invest. 2019;3(2):72–80. doi:10.1002/ped4.12129
   Google Scholar
• Arshad F, Saleem S, Jahan S, Tahir R. Staphylococcus aureusAssessment of vancomycin MIC creep phenomenon in methicillin-resistant isolates in a Tertiary care hospital of Lahore. Pak J Med Sci. 2020;36(7):1505–1510. doi:10.12669/pjms.36.7.327333235565
   PubMed Web of Science ®Google Scholar
• Khurana S, Mathur P, Malhotra R. Staphylococcus aureus at an Indian tertiary hospital: antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents. J Glob Antimicrob Res. 2019;17:98–102. doi:10.1016/j.jgar.2018.10.021
   Web of Science ®Google Scholar
• Aljohani S, Layqah L, Masuadi E, et al. Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia. J Infect Public Health. 2020;13(10):1576–1579. doi:10.1016/j.jiph.2020.07.00832859551
   PubMed Web of Science ®Google Scholar
• Kehrmann J, Kaase M, Szabados F, et al. Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem? Eur J Clin Microbiol Infect Dis. 2011;30(5):677–683. doi:10.1007/s10096-010-1140-721229280
   PubMed Web of Science ®Google Scholar